Health

Twincretin Shows Positive Effects in Phase 3 Trial in Diabetes

0
Twincretin Shows Positive Effects in Phase 3 Trial in Diabetes

Tirzepatide, the first dual GIP and GLP-1 receptor agonist in advanced testing, showed potent antihyperglycemic and weight loss effects in the first of several phase 3 studies in type 2 diabetes. Medscape Medical News
Read More

admin

New Laser Therapy Promising in Kids with Resistant Epilepsy

Previous article

Steroids Increase Infection Risk With CAR T-Cell Therapy in NHL

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Health